(Q73002526)
Statements
Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis (English)
Sükrü Kücüködük
Taner Sezer
Alisan Yildiran